HAMES NORMAN R

Pres and COO-West Operations Hames Norman R sold 10,000 shares at $72.74; post-transaction holdings 239,183 shares

Hames Norman R sold 10,000 shares (239.2K shares post-transaction) at $72.74 on 2025-09-10, representing a 4.0% reduction in holdings. The sale occurred near the 52-week trading range (current price $74.01 is -14.3% from the $86.38 peak). Looking at his prior five sales at RadNet, none were well-timed at the 90-day mark—all five prior sales saw positive 90-day returns (ranging from +12.4% to +19.0%), meaning the stock rose after each sale. This latest sale occurred against a backdrop of strong recent momentum (30-day +8.2%, 90-day +33.6%), which differs from the typical conditions of his prior RadNet exits. The company's elevated P/E of 1850.25 relative to net income of $14.5M and $498.2M quarterly revenue warrants attention for valuation context, though this single transaction alone provides limited directional insight into his view.

RadNet President/COO HAMES NORMAN R sells 8,447 shares for $506,820.00; stock now -30.2% from 52-week high.

HAMES NORMAN R, President and COO-West Operations, executed two separate sales totaling 8,447 shares for $506,820.00 on 2025-05-15, reducing his holdings by 25.3% from 33,336 to 24,889 shares at $60.00 per share. The timing is notable: RadNet trades at $60.26 (current price), down 30.2% from its 52-week high of $86.38, while the company reports deteriorating fundamentals with a net loss of $37,926,000.00 on revenue of $471,399,000.00 and a severely elevated P/E of 1506.50 reflecting near-zero profitability. At the same ticker, his prior five trades occurred predominantly in March 2025 (clustered within days), with measurable 90-day outcomes showing limited success (one prior 90-day result of -4.3%, others too recent for assessment). The substantial single-day reduction in a senior operational executive's stake amid depressed valuation and losses warrants close monitoring of forward guidance and cash position.

RadNet COO Norman Hames sells 15,000 shares for $741,300.00 (blended avg $49.42) over 3 days; stock down 17.3% in 30 days, 29.0% in 90 days.

Hames executed 4 separate sales totaling 15,000 shares (15.0K shares) for $741,300.00 across March 17–19, 2025, reducing his holdings by 5.6% to 252.0K shares post-transaction. The stock has declined 17.3% over the 30 days and 29.0% over the 90 days following his transaction period, a sharper contraction than his cross-ticker sell history (which shows 42.86% well-timed rate). At RDNT specifically, his prior 5 sales showed 3 of 5 well-timed at the 90-day horizon, suggesting moderate historical accuracy on this ticker. The current price of $50.71 is 41.3% below the 52-week high of $86.38, and the company carries a P/E of 1267.75 despite annual revenue growth of 13.2%, indicating market concerns about profitability relative to valuation; net income of $3.2M on $461.1M in quarterly revenue underscores the earnings challenge. The timing and magnitude of these sales warrant monitoring as they occur in a period of significant share-price compression.